Equities Analysts Issue Forecasts for RVMD Q3 Earnings
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Stock analysts at Leerink Partnrs issued their Q3 2025 earnings per share estimates for Revolution Medicines in a research report issued to clients and investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang expects that the company will post earnings per share of ($1.18) for the […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Stock analysts at Leerink Partnrs issued their Q3 2025 earnings per share estimates for Revolution Medicines in a research report issued to clients and investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang expects that the company will post earnings per share of ($1.18) for the […]
